🇺🇸 FDA
Pipeline program

NKTR-214

CA045-010

Phase 1 mab completed

Quick answer

NKTR-214 for Advanced Cancer is a Phase 1 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).

Program details

Company
NEKTAR THERAPEUTICS
Indication
Advanced Cancer
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials